Cancer anemia
Conditions
Interventions
Control group:Shengxuening tablet mimetic(sucrose plus dextrin)
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients are diagnosed as gastrointestinal tumours by imaging, pathological and/or cytological; 2. Patients meet the diagnostic criteria for mild or moderate anemia (mild anemia: Hb 90 to 120g/L or moderate anemia: Hb 60 to 90g/L), peripheral blood film shows small cell hypochromic anemia (MCV64.44µmol/L (360µg/dl); serum ferritin (SF) <14µg/L or transferrin saturation <0.15. 3. Aged 18 to 75 years; 4. KPS score above 70; 5. Life expecting longer than three months; 6. Any medication not be used to treat anemia and improving fatigue within one month before enrollment; 7. No chemotherapy regimen had been used before enrollment or had been discontinued for at least one month; 8. Voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. With heart, liver, kidney and other important organ damage. 2. Pregnant women and mental patients. 3. With gastric cancer invading the blood vessels caused by hematemesis, blood in the stool and other major bleeding. 4. Patients did not use the drug as prescribed. 5. Patient was forced to interrupt treatment due to serious side effects during the treatment period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean red blood cell volume;Hb concentration;Red blood cell distribution width;Hematocrit;Red blood cell count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum ferritin;Karnofsky;Transferrin;Serum iron;Total iron binding capacity; | — |
Countries
China
Contacts
Public ContactTian Shaodan
Outcome results
None listed